Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

Wed, 04th Nov 2020 10:38

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.

----------

FTSE 100 - WINNERS

----------

AstraZeneca, up 4.3%, Hikma, up 4.0% and GlaxoSmithKline, 2.6% higher. Pharmaceutical firms, often touted as defensive stocks, were on the up early on Wednesday following a volatile start for the FTSE 100 amid a tight and hard-to-call US election result. A "blue wave" sweep by Democrats might have brought more regulation for the pharmaceutical industry.

----------

FTSE 100 - LOSERS

----------

HSBC and Standard Chartered, down 3.4% and 5.2%. The two banking stocks were at the FTSE 100 on Wednesday morning, amid the political tensions in the US, giving back gains from Tuesday when they closed 4.3% higher and 3.9% higher, respectively.

----------

FTSE 250 - WINNERS

----------

Royal Mail, up 8.0%. The postal service provider surged after JPMorgan raised the stock to Overweight from Neutral.

----------

Marks & Spencer, up 4.8%. The retailer's interim performance was better than expected, despite swinging to a pretax loss of GBP87.6 million from a GBP158.8 million profit. Revenue for the six months to September declined 16% to GBP4.09 billion from GBP4.86 billion a year before.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Stobart Group, up 9.4%. The logistics, energy and aviation firm was hit by a reduction in passenger travel at Southend Airport. Revenue in the six months ended August dropped 29% to GBP53.2 million from GBP74.8 million, and Stobart's pretax loss ballooned to GBP77.4 million from GBP15.5 million. The company however, affirmed that it "remains focused on exiting Stobart Air" and is in talks with parties to dispose of its stake.

----------

Wishbone Gold, up 70%. The exploration firm said that geological consultants Terra Search spotted four magnetic targets, covering a total of 2.4 kilometres by 400 metres, at the Patersons Range gold project in Australia. Wishbone added that it has completed due diligence to acquire the project and will now move towards closing the acquisition.

----------

Gattaca, up 37%. The engineering and technology recruitment services firm said revenue slipped 15% in the year ended July 31 to GBP538.7 million from GBP634.3 million. Pretax profit fell 57% to GBP1.4 million from GBP3.4 million. But notes it will carry out an improvement plan which will see its Technology unit restructured. Adds that it will deliver GBP4 million in annual savings from costs during the year to November.

----------

CPL Resources, up 34% to 951.50 pence. The Dublin-based human resources firm has accepted a EUR317.8 million takeover from Outsourcing, a Tokyo-listed HR services provider. The EUR11.25 per share offer is a 36% premium to CPL closing price on Tuesday.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Tern, down 10%. The internet of things-focused investor announced a GBP860,000 investment to take a 23% stake in Talking Medicines, a provider of AI and machine learning services to the pharmaceutical industry.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.